Increased RANKL/OPG mRNA Ratio in Iliac Bone Biopsies From Women with Hip Fractures
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
RANKL (receptor activator of NF-kappaB) is a potent physiological inducer of osteoclastogenesis. Its actions are blocked by the decoy receptor osteoprotegerin (OPG), and treatment with OPG blocks bone resorption in postmenopausal women. Both positive and negative associations between serum OPG and bone mineral density (BMD) have been reported in the literature. We hypothesized that decreased OPG production relative to RANKL within bone itself could lead to increased risk of osteoporotic fracture. We included ten women with hip fracture (age 76.3 +/- 8.0 years, N.S, : hip BMD 0.686 +/- 1.3 g/cm2, P < 0.05) and 24 women with osteoarthrosis of the hip (age 72.8 +/- 7.2 years, hip BMD 0.832 +/- 1.1 g/cm(2)). Transiliac biopsies were obtained at the time of surgery. Total RNA was extracted from biopsies and reverse-transcribed. Real-time quantification of mRNA was performed with a SYBR Green I real time PCR assay, calculating relative gene expression with normalization of results for beta actin mRNA. Actin normalized mRNA levels for OPG and interleukin (IL)-6 were significantly lower in fracture patients, with a significantly higher RANKL/OPG ratio in patients with fractures. There was no significant difference in tumor necrosis factor (TNF), IL-1, IL-1ra, or IL-7 expression. IL-6 mRNA levels were lower in fracture patients (P < 0.05). The effect of increased RANKL/OPG ratio (Z = 2.08, P < 0.05) on fracture risk was additive to that of hip BMD T score (Z = -1.95, P < 0.05) when assessed using logistic regression. Elderly women with hip fractures exhibit an increased RANKL/OPG mRNA content of iliac bone. This is associated with increased fracture susceptibility, which is not in itself explained by low BMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the RANKL/OPG mRNA ratio in transiliac bone biopsies of women sustaining a hip fracture was increased compared with controls with osteoarthritis (387).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [387]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“In accordance with this, a positive correlation has been reported between bone resorption markers and the extent of RANKL expression on the surface of bone marrow cells in postmenopausal women [5].”
BackgroundHofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.997 · Cited by 561
Browner, W. S., Lui, L.-Y., & Cummings, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7192 · Cited by 506
Palmqvist, P., Persson, E., Conaway, H. H., & Lerner, U. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3353 · Cited by 486
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/s8756-3282(02)00915-8 · Cited by 477
Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 463
Hart, D. J., Mootoosamy, I., Doyle, D. V., & Spector, T. D. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.3.158 · Cited by 315
Toraldo, G., Roggia, C., Qian, W.-P., Pacifici, R., & Weitzmann, M. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136772100 · Cited by 291
Weitzmann, M. N., Cenci, S., Rifas, L., Brown, C., & Pacifici, R. (2000) · Blood · doi:10.1182/blood.v96.5.1873 · Cited by 265
Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238
Epidemiology of risk factors for osteoarthritis: systemic factors
Sowers, M. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00018 · Cited by 215
Correlates of osteoprotegerin levels in women and men.
Khosla, S., Arrighi, H. M., Melton, III, Atkinson, E. J., O'Fallon, W. M., Dunstan, C., & Riggs, B. L. (2002) · Osteoporosis International · doi:10.1007/s001980200045 · Cited by 205 · cited 1×
“In addition, OPG levels have been reported to be negatively correlated with BMD in elderly men [39].”
BackgroundRogers, A., Saleh, G., Hannon, R. A., Greenfield, D., & Eastell, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020396 · Cited by 200 · cited 1×
“Accordingly, treatment with OPG potently blocks bone resorption in postmenopausal women [8], but the relationship between endogenous serum OPG levels and bone mineral density (BMD) is unclear, as both positive and negative associations have been reported in the literature [ 9 , 10].”
ResultMurakami, T., Yamamoto, M., Yamamoto, M., Ono, K., Nishikawa, M., Nagata, N., Motoyoshi, K., & Akatsu, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9723 · Cited by 195
Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
Langdahl, B. L., Carstens, M., Stenkjaer, L., & Eriksen, E. F. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1245 · Cited by 191
GLOWACKI, J., HURWITZ, S., THORNHILL, T. S., KELLY, M., & LEBOFF, M. S. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200312000-00015 · Cited by 165
Marshall, D. A., Johnell, O., & Wedel, H. (1996) · Maturitas · doi:10.1016/0378-5122(96)81789-0 · Cited by 162
Interleukin-6 Deficiency Increases Inflammatory Bone Destruction
Balto, K., Sasaki, H., & Stashenko, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.744-750.2001 · Cited by 144
Fazzalari, N. L., Kuliwaba, J. S., Atkins, G. J., Forwood, M. R., & Findlay, D. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1015 · Cited by 129 · cited 1×
“In accordance with this, a small, carefully conducted study has demonstrated a decreased RANKL/ OPG mRNA ratio in intraoperative femoral bone samples from patients with OA of the hip compared with autopsy material from healthy subjects [37].”
ResultAkatsu, T., Murakami, T., Nishikawa, M., Ono, K., Shinomiya, N., Tsuda, E., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Higashio, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9294 · Cited by 123
Local factors in osteoarthritis
Sharma, L. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200109000-00017 · Cited by 120
Vidal, O., Sjögren, K., Eriksson, B. I., Ljunggren, Ö., & Ohlsson, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9035 · Cited by 114
Brändström, H., Jonsson, K. B., Vidal, O., Ljunghall, S., Ohlsson, C., & Ljunggren, Ö. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8993 · Cited by 113
Abrahamsen, B., Bonnevie-Nielsen, V., Ebbesen, E. N., Gram, J., & Beck-Nielsen, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1545 · Cited by 90
Self-citationOdgren, P. R., Kim, N., MacKay, C. A., Mason‐Savas, A., Choi, Y., & Marks, S. C. (2003) · Connective Tissue Research · doi:10.1080/03008200390181753 · Cited by 77
Interleukin-1 receptor antagonist: Discovery, structure and properties
Arend, W. P. (1990) · Progress in Growth Factor Research · doi:10.1016/0955-2235(90)90018-f · Cited by 61
Franchimont, N., Gangji, V., Durant, D., & CANALIS, E. M. (1997) · Endocrinology · doi:10.1210/endo.138.12.5559 · Cited by 50
Salamone, L. M., Whiteside, T. L., Friberg, D., Epstein, R. S., Kuller, L. H., & Cauley, J. A. (1998) · Calcified Tissue International · doi:10.1007/s002239900559 · Cited by 41
Huang, W., Drissi, M., O'Keefe, R. J., & Schwarz, E. M. (2003) · Calcified Tissue International · doi:10.1007/s00223-003-0059-8 · Cited by 21
Abrahamsen, B., Stilgren, L. S., Rettmer, E., Bonnevie‐Nielsen, V., & Beck‐Nielsen, H. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-2037-y · Cited by 17
Self-citation
Research works printed but not linked: 2
- WS Browner, 2001, J Clin Endocrinol Metab, 86, 63l
- P Bordier, 1964, Pathol Microbiol, 12, 1238
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.
KOSTENUIK, P. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.06.005 · Cited by 281
Seriwatanachai, D., Thongchote, K., Charoenphandhu, N., Pandaranandaka, J., Tudpor, K., Teerapornpuntakit, J., Suthiphongchai, T., & Krishnamra, N. (2008) · Bone · doi:10.1016/j.bone.2007.11.008 · Cited by 175
Rauner, M., Sipos, W., & Pietschmann, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000098223 · Cited by 132
Metadata
- Authors
- Abdallah, B. M., Stilgren, L. S., Nissen, N., Kassem, M., Jørgensen, H. R. I., & Abrahamsen, B.
- Affiliations
- Odense University Hospital (DK)
- Corresponding author
- Abrahamsen, Bo
- Venue
- Calcified Tissue International
- Published
- 2004-11-18
- Volume
- 76
- Issue
- 2
- Pages
- 90-97
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2033504273
- Cited by
- 60
- References
- 41
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- RANKL/OPG ratio, osteoprotegerin, RANKL, hip fracture, osteoporotic fractures, iliac bone biopsy, interleukin-6, bone mineral density, postmenopausal women, osteoclastogenesis, fracture risk, older women
- MeSH terms
- Aged, Aged, 80 and over, Biopsy, Carrier Proteins, Female, Hip Fractures, Humans, Ilium, Membrane Glycoproteins, Middle Aged, RNA, Messenger, Biomarkers, Absorptiometry, Photon, Bone Density, Interleukin-6, Gene Expression, Cytokines, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.